Trial Profile
A randomized, double-blind, placebo-controlled, multicenter phase III trial to investigate the efficacy and safety of ganaxolone in adults with focal onset seizures
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 11 Sep 2015
Price :
$35
*
At a glance
- Drugs Ganaxolone (Primary)
- Indications Epilepsy; Seizures
- Focus Registrational; Therapeutic Use
- Sponsors Marinus Pharmaceuticals
- 11 Sep 2015 New trial record
- 09 Sep 2015 This trial is expected to begin in 2016, according to a Marinus Pharmaceuticals media release. The company plans to submit the protocol of this trial to the FDA for a special protocol assessment.